Toxic shock syndrome is an inflammatory condition caused by a bacterial infection that, like MIS-C, can result in low blood pressure, fever, and rash
This information should be interpreted with a qualified healthcare provider to inform personalized dosing strategies that reduce overdose risk while optimizing therapeutic outcomes
In this conversation on The Silent Decade with Jaiwant Rangi, MD, FACE, the discussion highlights research that challenges a long-standing assumption: that type 2 diabetes is a single, uniform condition
As a result, the 2024 report concludes that the drug development pipeline for Parkinsons is robust, but more progress needs to be made with late-stage testing of treatments to slow the disease, with Cure Parkinsons adding: With the importance of disease-modifying therapies for an eventual cure for Parkinsons, there is a clear need for further initiatives that will facilitate the progression of drugs through the clinical trial pipeline and into subsequent phases of testing. Read more about Parkinsons research here.